0 |
28/12/2016 8:06 AM |
|
Appendix 3Y - Change of Director's Interest Notice 2 pages 200.1KB |
1 |
23/12/2016 4:37 PM |
|
Issue of Performance Rights - Appendix 3B 11 pages 383.1KB |
2 |
22/12/2016 11:52 AM |
|
MXC Operations Update 4 pages 734.3KB |
3 |
15/12/2016 9:55 AM |
|
New Panax Acquisition Agreement Signed, Settlement Imminent 4 pages 270.1KB |
4 |
07/12/2016 1:23 PM |
|
MXC Appoints ex Revlon Director to Fast Track Cosmetic Sales 3 pages 315.4KB |
5 |
02/12/2016 11:28 AM |
|
First Major European Sales and Revenue for MGC Derma Range 3 pages 288.6KB |
6 |
29/11/2016 8:17 PM |
|
Results of Annual General Meeting 1 page 128.5KB |
7 |
10/11/2016 6:53 PM |
|
Cleansing Prospectus Closed 1 page 135.7KB |
8 |
10/11/2016 2:12 PM |
|
Appendix 3B - Issue of Listed Options 12 pages 483.7KB |
9 |
09/11/2016 4:22 PM |
|
Cleansing Prospectus 32 pages 338.4KB |
10 |
07/11/2016 10:06 AM |
|
EU Registration Commenced for CBD Derma Product Sales 2 pages 187.2KB |
11 |
27/10/2016 9:45 AM |
|
September Quarter Activity and Cashflow Report 9 pages 321.6KB |
12 |
26/10/2016 5:18 PM |
|
Appendix 4G and Corporate Governance Statement 20 pages 410.5KB |
13 |
26/10/2016 8:58 AM |
|
Annual Report 2016 37 pages 1.9MB |
14 |
25/10/2016 7:35 PM |
|
Notice of Annual General Meeting/Proxy Form 23 pages 476.0KB |
15 |
21/10/2016 1:56 PM |
|
Appendix 3Y - Change of Director's Interest Notice x 3 7 pages 198.5KB |
16 |
17/10/2016 7:44 PM |
|
Issue of Performance Rights - Appendix 3B 12 pages 503.7KB |
17 |
11/10/2016 9:39 AM |
|
Listed Options now Quoted - ASX Code MXCOD 1 page 123.3KB |
18 |
06/10/2016 1:40 PM |
|
Issue of Listed Options from Capital Raisings - Appendix 3B 13 pages 527.1KB |
19 |
29/09/2016 12:32 PM |
|
Operations Update - Multiple Revenue Streams Imminent 3 pages 224.6KB |
20 |
27/09/2016 7:20 PM |
|
Results of General Meeting 1 page 138.0KB |
21 |
21/09/2016 10:04 AM |
|
New Med Cannabis White Paper Developed with Uni of Sydney 2 pages 212.7KB |
22 |
07/09/2016 6:16 PM |
|
Cleansing Prospectus Closed - No Shares Issued 1 page 125.2KB |
23 |
06/09/2016 6:16 PM |
|
Cleansing Prospectus 31 pages 346.1KB |
24 |
01/09/2016 1:06 PM |
|
Strategic Agreement signed with Epilepsy Action Australia 2 pages 600.7KB |
25 |
30/08/2016 10:14 AM |
|
Q&A with Nativ Segev, MGC Pharmaceuticals Managing Director 1 page 108.9KB |
26 |
29/08/2016 1:29 PM |
|
Appendix 4E and Audited 2016 Financial Report 69 pages 1.7MB |
27 |
26/08/2016 5:46 PM |
|
Notice of General Meeting/Proxy Form 28 pages 632.9KB |
28 |
23/08/2016 11:50 AM |
|
Psoriasis and Acne Tests Advancing Ahead of Product Launch 2 pages 169.4KB |
29 |
12/08/2016 5:21 PM |
|
Appendix 3B - Issue of Consultant Shares 12 pages 374.2KB |
30 |
11/08/2016 9:56 AM |
|
Sale of Lingokoto and Bouroubourou Gold Exploration Assets 1 page 108.6KB |
31 |
28/07/2016 12:37 PM |
|
June Quarterly Activity and Cashflow Report 10 pages 1.3MB |
32 |
20/07/2016 12:38 PM |
|
Q&A with Dr Ross Walker, MGC Pharmaceuticals Director 1 page 108.7KB |
33 |
13/07/2016 10:02 AM |
|
Leading Epilepsy Expert Joins MXC Strategic Advisory Board 3 pages 207.4KB |
34 |
27/06/2016 9:31 AM |
|
First Revenues Received from Californian Cosmetics Deal 2 pages 169.9KB |
35 |
24/06/2016 5:39 PM |
|
Resignation of Director - Appendix 3Z 3 pages 275.8KB |
36 |
23/06/2016 6:24 PM |
|
Appendix 3B - Option Conversion 8 pages 255.4KB |
37 |
15/06/2016 11:29 AM |
|
MXC's First Crops Planted at European CBD Production Farm 3 pages 1.2MB |
38 |
31/05/2016 4:03 PM |
|
Completion of Priority Offer Share Allotment - Appendix 3B 13 pages 469.0KB |
39 |
30/05/2016 9:41 AM |
|
Health Canada Approves MGC Derma CBD Cosmetics 2 pages 167.0KB |
40 |
27/05/2016 6:05 PM |
|
Appendix 3Y - Change of Director's Interest Notice 3 pages 195.5KB |
41 |
27/05/2016 9:51 AM |
|
Chairman's Update to Shareholders 2 pages 172.3KB |
42 |
25/05/2016 9:22 AM |
|
FDA Approval Granted and First US Distribution Deal Signed 2 pages 173.5KB |
43 |
23/05/2016 9:38 AM |
|
Trading Halt 2 pages 359.5KB |
44 |
20/05/2016 9:29 AM |
|
Shareholder Priority Offer Closed Early - Oversubscribed 1 page 107.1KB |
45 |
16/05/2016 6:51 PM |
|
Appendix 3B - Prospectus Priority Offer 12 pages 374.1KB |
46 |
16/05/2016 5:56 PM |
|
Prospectus - Priority Offer 40 pages 400.7KB |
47 |
16/05/2016 11:39 AM |
|
Investor Presentation - May 2016 21 pages 1.7MB |
48 |
16/05/2016 10:06 AM |
|
Form 605 - Notice of ceasing to be a substantial holder x 2 2 pages 150.1KB |
49 |
12/05/2016 3:01 PM |
|
Priority Offer Timetable - Update 2 pages 166.6KB |
50 |
12/05/2016 12:18 PM |
|
Completion and Allotment of Placement Shares 1 page 106.2KB |
51 |
11/05/2016 7:08 PM |
|
Appendix 3B Updated - Prospectus 12 pages 386.5KB |
52 |
11/05/2016 6:54 PM |
|
Supplementary Prospectus 10 pages 212.5KB |
53 |
11/05/2016 3:37 PM |
|
Appendix 3Y - Change of Director's Interest Notice 3 pages 196.0KB |
54 |
11/05/2016 3:27 PM |
|
Appendix 3B - Option Conversion 8 pages 254.3KB |
55 |
11/05/2016 9:45 AM |
|
European Commission Approves MGC Derma Cosmetics Products 2 pages 169.3KB |
56 |
10/05/2016 9:36 AM |
|
Reinstatement to Official Quotation 1 page 93.8KB |
57 |
10/05/2016 9:36 AM |
|
ASX Approval of Panax Transaction and Capital Raising Update 2 pages 174.0KB |
58 |
09/05/2016 9:46 AM |
|
Senegal Gold Assets - Project Status Update 1 page 106.2KB |
59 |
04/05/2016 3:34 PM |
|
Suspension from Official Quotation 1 page 257.4KB |
60 |
04/05/2016 12:40 PM |
|
Prospectus 39 pages 461.7KB |
61 |
04/05/2016 9:48 AM |
|
MXC to Raise $5.0m - Capital Raising Oversubscribed 3 pages 160.0KB |
62 |
02/05/2016 10:11 AM |
|
Response to ASX Aware Letter 5 pages 557.4KB |
63 |
02/05/2016 9:25 AM |
|
Trading Halt 2 pages 361.7KB |
64 |
02/05/2016 8:16 AM |
|
March Quarterly Activity and Cashflow Report 8 pages 284.3KB |
65 |
27/04/2016 10:21 AM |
|
MXC to Acquire Licensed European Medical Cannabis Company 4 pages 1.1MB |
66 |
22/04/2016 9:55 AM |
|
Trading Halt 2 pages 364.0KB |
67 |
18/04/2016 7:31 PM |
|
Response to ASX Price Query 4 pages 468.9KB |
68 |
13/04/2016 10:30 AM |
|
Launch of Online Store - First Retail Sales of CBD Cosmetics 2 pages 171.0KB |
69 |
04/04/2016 11:14 AM |
|
MXC to Enter Australian Medicinal Cannabis Market 3 pages 189.3KB |
70 |
29/03/2016 9:36 AM |
|
MXC Publishes First Australian Med Cannabis White Paper 3 pages 173.1KB |
71 |
24/03/2016 11:12 AM |
|
MXC Secures First Cosmetics Sales Agreement 2 pages 130.1KB |
72 |
03/03/2016 9:19 AM |
|
Agreement with SipNose takes MXC into Global Epilepsy Market 3 pages 264.5KB |
73 |
29/02/2016 7:41 PM |
|
Half Yearly Report and Accounts 25 pages 599.7KB |
74 |
25/02/2016 10:03 AM |
|
Legalisation of Medical Cannabis Fast Tracks Aus Opportunity 2 pages 151.2KB |
75 |
23/02/2016 10:52 AM |
|
Investor Report by the Next Bio Tech 1 page 93.0KB |
76 |
23/02/2016 9:51 AM |
|
Managing Director's Update to Shareholders 2 pages 134.7KB |
77 |
19/02/2016 2:47 PM |
|
Capital structure 1 page 93.9KB |
78 |
19/02/2016 2:43 PM |
|
Securities trading policy 13 pages 277.5KB |
79 |
19/02/2016 2:40 PM |
|
Pro forma balance sheet as at 31 January 2016 1 page 121.2KB |
80 |
19/02/2016 2:40 PM |
|
MGC Pharma (UK) Limited's account for 26/8/15 - 30/9/15 15 pages 1.2MB |
81 |
19/02/2016 2:37 PM |
|
Corporate governance statement 10 pages 224.8KB |
82 |
19/02/2016 2:37 PM |
|
Terms and conditions of Performance Shares 2 pages 126.6KB |
83 |
19/02/2016 2:36 PM |
|
Confirmations 1 page 105.0KB |
84 |
19/02/2016 2:36 PM |
|
Appendix 1A and Information Form and Checklist 18 pages 339.1KB |
85 |
19/02/2016 2:35 PM |
|
Constitution 67 pages 473.1KB |
86 |
19/02/2016 2:35 PM |
|
Distribution schedule & Top 20 Holders 1 page 107.7KB |
87 |
19/02/2016 2:35 PM |
|
Pre-reinstatement disclosure 1 page 260.6KB |
88 |
19/02/2016 2:35 PM |
|
ASX Notice - Reinstatement to Official Quotation 2 pages 283.0KB |
89 |
19/02/2016 2:35 PM |
|
Reinstatement to Official Quotation (23/02/2016) 1 page 257.0KB |
90 |
17/02/2016 2:12 PM |
|
Form 603 - Notice of initial substantial holder x 2 4 pages 156.4KB |
91 |
17/02/2016 2:10 PM |
|
Form 605 - Notice of ceasing to be a substantial holder x 2 3 pages 349.7KB |
92 |
16/02/2016 6:19 PM |
|
Appendix 3X - Initial Director's Interest Notice x 3 6 pages 179.2KB |
93 |
16/02/2016 6:17 PM |
|
Appendix 3Z - Final Director's Interest Notice 2 pages 166.2KB |
94 |
16/02/2016 9:34 AM |
|
Completion of Acquisition - Appendix 3B 13 pages 406.4KB |
95 |
12/02/2016 12:32 PM |
|
Managing Director's Update to Shareholders 2 pages 138.1KB |
96 |
11/02/2016 7:23 PM |
|
Supplementary Prospectus 4 pages 143.6KB |
97 |
11/02/2016 7:22 PM |
|
Issue of Supplementary Prospectus and Option Cancellation 1 page 97.1KB |
98 |
11/02/2016 12:45 PM |
|
MGC Welcomes Medical Cannabis Legislation Change 3 pages 161.5KB |
99 |
01/02/2016 10:29 AM |
|
December Quarterly Activity and Cashflow Report 9 pages 234.4KB |
100 |
27/01/2016 11:16 AM |
|
Conditional Reinstatement Letter Issued 1 page 81.7KB |
101 |
04/01/2016 9:11 AM |
|
Prospectus Offers Closed 1 page 87.8KB |
102 |
04/01/2016 9:11 AM |
|
App 3B Issue of July 15 Unlisted Options 12 pages 159.4KB |